Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Chupp

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
American Journal of Respiratory Cell and Molecular Biology|June 30, 2025
Sex-biased Gene Expression Underlies Immune Dysfunction in AsthmaShannon Kay, Haseena Rajeevan, Moeun Son, et al.
Journal of Personalized Medicine|April 3, 2021
Drug Repurposing to Treat Glucocorticoid Resistance in AsthmaAlberta L Wang, Ronald Panganiban, Weiliang Qiu, et al.
The Journal of Allergy and Clinical Immunology|February 10, 2020
An endothelial microRNA-1-regulated network controls eosinophil trafficking in asthma and chronic rhinosinusitisAsawari Korde, Farida Ahangari, Maria Haslip, et al.
The European Respiratory Journal|August 21, 2020
Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysisTim Harrison, Giorgio Walter Canonica, Geoffrey Chupp, et al.
Frontiers in Immunology|May 1, 2023
Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES studyIan Pavord, Frances Gardiner, Liam G Heaney, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 16, 2023
Mepolizumab Reduces Systemic Corticosteroid Use in Chronic Rhinosinusitis With Nasal PolypsGeoffrey Chupp, Isam Alobid, Njira L Lugogo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2023
Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: The NAVIGATOR studyAndrew Menzies-Gow, Arnaud Bourdin, Geoffrey Chupp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammationMin-Jong Kang, Robert J Homer, Amy Gallo, et al.
BMJ Open Respiratory Research|May 18, 2026
Integrated molecular networks reveal latent components distinguishing type 2-high and type 2-low asthmaMaria Ramirez, Maria Paula Diaz, Ningya Wang, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2022
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polypsLarry Borish, Noam A Cohen, Geoffrey Chupp, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
American Journal of Respiratory Cell and Molecular Biology|June 30, 2025
Sex-biased Gene Expression Underlies Immune Dysfunction in AsthmaShannon Kay, Haseena Rajeevan, Moeun Son, et al.
Journal of Personalized Medicine|April 3, 2021
Drug Repurposing to Treat Glucocorticoid Resistance in AsthmaAlberta L Wang, Ronald Panganiban, Weiliang Qiu, et al.
The Journal of Allergy and Clinical Immunology|February 10, 2020
An endothelial microRNA-1-regulated network controls eosinophil trafficking in asthma and chronic rhinosinusitisAsawari Korde, Farida Ahangari, Maria Haslip, et al.
The European Respiratory Journal|August 21, 2020
Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysisTim Harrison, Giorgio Walter Canonica, Geoffrey Chupp, et al.
Frontiers in Immunology|May 1, 2023
Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES studyIan Pavord, Frances Gardiner, Liam G Heaney, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 16, 2023
Mepolizumab Reduces Systemic Corticosteroid Use in Chronic Rhinosinusitis With Nasal PolypsGeoffrey Chupp, Isam Alobid, Njira L Lugogo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2023
Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: The NAVIGATOR studyAndrew Menzies-Gow, Arnaud Bourdin, Geoffrey Chupp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammationMin-Jong Kang, Robert J Homer, Amy Gallo, et al.
BMJ Open Respiratory Research|May 18, 2026
Integrated molecular networks reveal latent components distinguishing type 2-high and type 2-low asthmaMaria Ramirez, Maria Paula Diaz, Ningya Wang, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2022
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polypsLarry Borish, Noam A Cohen, Geoffrey Chupp, et al.
Pageof 6